New research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2026 has ...

A drug that showed promise in treating a sleep disorder could potentially help slow symptoms, experts say.

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people ...

Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACE™ Phase 1b ...

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million ...

A five-year-old boy has been diagnosed with an exceptionally rare genetic condition after his parents noticed he wasn't ...

A potential cure for the deadly “tradie” disease silicosis is a step closer after Australian scientists discovered for the ...

A study published in Cannabis and Cannabinoid Research examined the effects of medical cannabis on patients diagnosed with ...

Stacked appointments, new medications and meeting with the requirements of insurance policies are routine for those living with Parkinson’s disease. In rural states like Wyoming, patients ...

Parkinson’s disease is a long-term brain disorder that slowly damages nerve cells involved in movement. It affects millions of people around the world and becomes more common with age. The disease is ...

Researchers at the Icahn School of Medicine at Mount Sinai have found that patients with Parkinson's disease undergoing deep ...

In a world first Australian researchers will test a one-off therapy that could replace damaged brain cells in people with ...